|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/675 | |
| A61K 31/506 | |||
| A61K 31/404 | |||
| A61K 31/436 | |||
| A61K 31/665 | |||
| A61K 31/44 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61K 45/06 | |||
| A61K 31/4045 | |||
| A61K 31/4412 | |||
| A61P 35/02 | |||
| A61P 43/00 |
| (11) | Patento numeris | 3311835 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17187097.5 |
| Europos patento paraiškos padavimo data | 2011-07-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-04-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-03-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 363610 P | 2010-07-12 | US | |
| 201161470412 P | 2011-03-31 | US | |
| 201161470812 P | 2011-04-01 | US |
| (72) |
KROLL, Stewart, US
CURD, John, US
HART, Charles, US
SUN, Jessica, US
|
| (73) |
ImmunoGenesis, Inc. ,
909 Fannin, Suite 2000, Houston, TX 77010,
US
|
| (54) | ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS AND ANTIANGIOGENIC AGENTS FOR THE TREATMENT OF CANCER |
| ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS AND ANTIANGIOGENIC AGENTS FOR THE TREATMENT OF CANCER |